1. Pink Sheet
  2. >>Geography
  3. >>Asia
  4. >>China

China Gene-Edited Babies' Creator: “I Am Willing To Take Criticism”

 
• By Brian Yang

In his first public appearance since claiming creation of the world’s first gene-edited babies, Chinese researcher He Jiankui apologized but said he is willing to face criticism for the sake of the families involved.

Screenshot of He Jiankui presenting at Second Gene Editing on Genome, held in Hong Kong, Nov.28, 2018
He Jiankui presenting at 2nd International Summit on Human Genome Editing in Hong Kong Nov. 28, 2018 • Source: PinkSheet

It seems that the whole world is waiting to learn how a little-known researcher from China stunned the globe by announcing the birth of genetically modified twin babies using controversial gene-editing technology on human embryos.

“First, I must apologize, the results of our whole study were leaked due to indiscreet reasons, so I must share the data with you,” He Jiankui told a packed auditorium in Hong Kong

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from China

More from Asia

Japan Looks To Build Domestic Capacity In New Modalities

 
• By Lisa Takagi

Japan's trade ministry is providing new support to build domestic capacity for new modalities including cell and gene therapies, as part of wider efforts to support the national bioventure ecosystem.

Pipeline To Product – What Is Driving Cell And Gene Therapy Progress In India?

 
• By Vibha Ravi

US-based Colossal Labs has claimed to bring back the dire wolf from extinction. While the science is not as dramatic in India yet, cell and gene therapies are making progress as treatments for cancer and other diseases. Pink Sheet takes a look at what is driving CGT success and growth.

Japan Identifies Drugs ‘In Urgent Need’ Of Development

 
• By Lisa Takagi

Artesunate for malaria, TB drug pretomanid and omadacycline for pneumonia and skin infections are among the drugs identified by Japanese regulatory authorities in urgent need of domestic development.